Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications

Jeffrey S. Flier, Lisa H. Underhill, Michael Brownlee, Anthony Cerami, Helen Vlassara

Research output: Contribution to journalReview article

2212 Scopus citations


IN this seminar we review recent studies suggesting that the central pathologic features of diabetic complications are caused by the hyperglycemia-accelerated formation of nonenzymatic advanced glycosylation end products in tissue. We will emphasize new research findings with important clinical implications, since older information is available in previously published reviews.12 Other biochemical mechanisms by which hyperglycemia may contribute to the development of diabetic complications are not discussed here, since they are comprehensively reviewed elsewhere.3 4 5 6 7 8 Differences between Early and Advanced Glycosylation Products The central pathophysiologic features of diabetic vascular complications are an abnormal leakage of proteins from the circulation and a progressive.

Original languageEnglish (US)
Pages (from-to)1315-1321
Number of pages7
JournalNew England Journal of Medicine
Issue number20
StatePublished - May 19 1988


ASJC Scopus subject areas

  • Medicine(all)

Cite this